Sequence Identity in Peptide Analysis

Sequence identity measures how closely the amino acid chain of an analyzed peptide matches the expected reference sequence. In analytical laboratory work, it is the confirmation that the synthesized molecule is exactly what the label states: not a variant with a substituted residue, not a structurally similar analog. It is a separate data point from purity, and a rigorous certificate of analysis reports both independently.

Why the amino acid sequence defines a peptide

A peptide is a chain of amino acids connected by peptide bonds. The precise order of that chain — the sequence — determines how the molecule folds, which functional groups are exposed, and which structures it can interact with in the laboratory environment. Changing a single amino acid at a critical position can completely alter the compound's behavior.

When a synthesized peptide lot arrives, the relevant question is not only how much material is in the vial. The question that matters is whether what is in the vial has the correct sequence.

A concrete example: sermorelin has 29 amino acids. If synthesis incorporates a leucine where an isoleucine belongs — two amino acids with identical molecular mass — simple mass spectrometry cannot distinguish them. Tandem fragmentation is required to separate the two residues and confirm the chain is correct.

How sequence identity is determined

The standard method in analytical laboratories is tandem mass spectrometry (MS/MS). It works in two stages.

First stage — total mass. The peptide is ionized and the mass-to-charge ratio of the intact compound is measured. This confirms the molecular formula and rules out contaminants with a different mass.

Second stage — fragmentation. The peptide ion is fragmented inside the spectrometer. The resulting fragments correspond to portions of the chain, and their pattern allows the sequence to be reconstructed amino acid by amino acid. Fragments retaining the N-terminal end are called b ions; those retaining the C-terminal end are y ions. When the combined set of b and y ions covers the full length of the peptide, sequence identity is 100%.

An older method is Edman degradation: the N-terminal amino acid is removed one at a time and each is identified by chromatography. It remains accurate for short peptides of up to roughly 20 residues, but for longer chains and high-throughput laboratories, MS/MS is faster and more sensitive.

The analytical criteria applied to PeptoClinic Research Supply lots are described in the quality section.

Sequence identity and purity: two different questions

This is the most common point of confusion when reading a certificate of analysis.

HPLC purity measures what proportion of the total chromatogram signal corresponds to the peak of the compound of interest. A purity of 99.7% means that 99.7% of the UV-active material elutes at the expected retention time. It does not say whether that peak has the correct sequence.

Sequence identity says whether the predominant compound is the peptide stated on the label. Two peptides with different sequences but similar hydrophobicity can co-elute on the same column: HPLC records them as a single peak.

The four combinations that can appear on a report:

• High purity and confirmed sequence: the correct outcome.
• High purity and sequence unconfirmed: what was measured is unknown.
• Confirmed sequence and low purity: the compound is correct, but impurities are present.
• Sequence does not match: the lot is incorrect regardless of the purity percentage.

For laboratory research, both parameters matter. One data point without the other is insufficient to characterize a lot.

What to read on a certificate of analysis

A useful CoA includes at minimum:

• Compound name, molecular formula, and CAS number or sequence in single-letter notation.
• HPLC purity: main peak area over the total, with chromatographic conditions (column, gradient, wavelength).
• Molecular mass confirmation: calculated mass vs. found mass by MS.
• Sequence confirmation: method used (MS/MS or Edman) and sequence coverage achieved.
• Issuing laboratory name, date of analysis, and task or lot number.
• A verification link or code the laboratory can independently confirm.

Lots available through the PeptoClinic catalog are accompanied by reports from Janoshik Analytical, an independent laboratory specializing in peptide analysis. The retatrutide lot analyzed in April 2026 (task 136921) returned 99.893% HPLC purity; the MOTS-c lot (task 136923), 99.669%. Both reports include a task number verifiable directly in the laboratory's system.

Direct CoA verification

The value of a certificate of analysis is not in the printed document. It is in the issuing laboratory being able to independently confirm that a given task number corresponds to a given analysis. If the verification system does not exist or returns an error, the document is no more reliable than the image that generated it. Before trusting a CoA, locate the laboratory, open its online verifier, and enter the task number.

Cases where sequence identity is decisive

Position isomers. Some peptides have pairs of amino acids with identical molecular weights in interchangeable positions. The total mass of the peptide is identical in both variants; only MS/MS fragmentation distinguishes which is which.

Synthesis modifications. C-terminal amidation, N-terminal acetylation, and cyclization change the masses of the chain termini but do not always alter the HPLC retention time. MS/MS reveals them in the fragment spectrum.

High-similarity analogs. BPC-157 and related synthetic variants have similar masses. Confirming the exact sequence rules out confusion between analogs when working with lots from different sources.

Research material: laboratory use only

The peptides PeptoClinic Research Supply provides to researchers are material for Research Use Only (RUO): in vitro and laboratory research. They are not approved or intended for human or veterinary consumption, diagnosis, or treatment.

Nothing in this post is clinical guidance, an administration protocol, or a therapeutic indication. The sequence identity analyses described here are relevant for characterizing research materials in the context of laboratory work. Published PubMed literature on these methods is peer-reviewed science; the laboratory data accompanying a lot is analytical documentation. Neither constitutes a clinical use indication.